Belite Bio, Inc (BLTE) research: valuation against peers, fundamentals over time, risk and news coverage
ChartVs peersValuationValue mapQuartersScaleMarginsTrajectoryCash qualityPer shareReinvestmentBalance sheetStreetRiskSeasonalityOur coverage
BLTE
Belite Bio, IncUSD
183.16
-5.02% today
Market cap
—
P/E trailing
—
P/E forward
—
EV/EBITDA
—
Op margin
—
Rev growth
—
Div yield
—
Beta
—
Price navigator — BLTE
No data in this window.
INDY NEWS coverage of BLTE1
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- SPECIAL REPORTBEARISHBelite Bio Executives Sell Over $30 Million Combined in Company Shares
Belite Bio's CEO sold $19.08 million and its CFO sold $12.8 million in company shares, a combined total exceeding $30 million from the two top executives.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.